KLOTEN, Switzerland: Nobel Biocare, a global leader in dental regenerative solutions, is celebrating the tenth anniversary of its creos brand. Over the past decade, creos has become synonymous with quality and innovation, offering exceptional products that have reshaped the landscape of dental regeneration.
A Legacy of Excellence
First introduced at the 2014 Academy of Osseointegration Annual Meeting, creos has evolved into a trusted name in regenerative dentistry. With a portfolio now exceeding 20 products and supported by three in-house manufacturing sites, the brand has consistently delivered reliable clinical outcomes through innovative design and rigorous research.
A Milestone Product: Creos Xenoprotect
At the heart of the creos product line is creos xenoprotect, a resorbable collagen membrane recognized for its superior handling, predictable resorption, and versatility in guided bone and tissue regeneration. Backed by over 16 published clinical studies from experts like Drs. Bastian Wessing and Arturo Llobell, creos xenoprotect has set a high standard in regenerative solutions. This year, it achieved a remarkable milestone with the sale of its one-millionth unit, reflecting widespread trust within the dental community.
Building on this success, the creos portfolio expanded in 2016 to include creos xenogain and creos xenogain collagen, premium xenogenic bone grafting materials. The addition of wound dressings, sutures, and membrane fixation kits has further cemented the brand’s reputation for comprehensive regenerative offerings.
Strategic Acquisitions Strengthening the Brand
Nobel Biocare’s journey to regenerative leadership has been bolstered by strategic acquisitions:
- Matricel: Known for innovative biomaterial solutions, including resorbable collagen membranes, Matricel has enhanced Nobel Biocare’s capabilities.
- Osteogenics: Recognized for its Cytoplast dPTFE membranes, Osteogenics has diversified the company’s offerings for guided bone and tissue regeneration.
- Mimetis: A leader in synthetic bone grafting substitutes, Mimetis has brought advanced technology and expertise to Nobel Biocare.
These acquisitions have allowed Nobel Biocare to integrate cutting-edge technologies and expand its regenerative product range to meet diverse clinical needs.
Charting the Future of Dental Regeneration
As Nobel Biocare celebrates this milestone, its commitment to the future remains steadfast. Ongoing investments in research and development and the integration of advanced technologies ensure that the company will continue to set new benchmarks in dental regenerative solutions.
The creos brand represents more than a decade of achievements—it embodies Nobel Biocare’s vision for innovation and excellence in the ever-evolving field of dental care.
Related topics:
X-MIND Optima 3D: Revolutionizing Dental Imaging with Precision and Efficiency
Nobel Biocare Global Symposium 2025 to Showcase Innovations in Implantology and Digital Dentistry
Start Your Smile Transformation This Holiday Season with ClearWave Dental & Aesthetics
